Table 1 Fluid challenge characteristics and hemodynamic monitoring in the included studies
Authors | Year | n | FCs | Volume infused (ml) | Infusion time (min) | Fluid type | Monitoring devices | Reference Variable | Responders (%) | Authors | Year | n | FCs | Volume infused (ml) | Infusion time (min) | Fluid type | Monitoring devices | Reference Variable | Responders (%) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hofer C.K., et al. [44] | 2005 | 40 | 40 | 10 ml/kg | 20 | HES 6% | PiCCOplus | SV ≥ 10% | 60.0 | De Broca B., et al. [28] | 2016 | 60 | 60 | 500 | 10 | Saline 0.9% | CardioQ | SV ≥ 15% | 62.0 |
Preisman S., et al. [45] | 2005 | 18 | 70 | 250 | 5–7 | Colloids | PiCCO | VTI ≥ 15% | 46.0 | Biais M., et al. [22] | 2017 | 44 | 88 | 250 | 10 | Saline 0.9% | ProAQT | SV ≥ 10% | 31.8 |
Cannesson M., et al. [46] | 2007 | 25 | 25 | 500 | 10 | HES 6% | PAC | CI ≥ 15% | 60.0 | Biais M., et al. [23] | 2017 | 28 | 28 | 250 | > 10 | Saline 0.9% | ProAQT | SV ≥ 10% | 57.1 |
Lee J.-H., et al. [47] | 2007 | 20 | 20 | 7 ml/kg | 1mL/kg/min | HES 6% | TEE | SVI ≥ 15% | 55.0 | Biais M., et al. [27] | 2017 | 41 | 41 | 250 | 10 | Saline 0.9% | ProAQT | SV ≥ 10% | 51.2 |
Cannesson M., et al. [48] | 2008 | 25 | 25 | 500 | 10 | HES 6% | PAC | CI ≥ 15% | 68.0 | Messina A., et al. [49] | 2017 | 46 | 46 | 500 | 10 | Saline 0.9% | MostCare | CI > 15% | 41.3 |
Cannesson M., et al. [50] | 2008 | 25 | 25 | 500 | > 10 | HES 6% | PAC | CI ≥ 15% | 64.0 | Min J.J., et al. [51] | 2017 | 49 | 49 | 6mL/kg | ≤10 | Saline 0.9% | PAC | NA | 42.0 |
Cannesson M., et al. [52] | 2009 | 25 | 25 | 500 | 10 | HES 6% | Mixed | CI ≥ 15% | 68.0 | Jeong D.M., et al. [53] | 2017 | 79 | 79 | 7mL/kg | 30 | HES 6% | Vigileo/Flotrac | SVI ≥ 10% | 37.0 |
Derichard A., et al. [54] | 2009 | 11 | 56 | 200–500 | 8–15 | Colloids | Mixed | CI ≥ 15% | 57.1 | Min J.J., et al. [55] | 2017 | 40 | 40 | 6mL/kg | ≤10 | HES 6% | NICOM | CI ≥ 12% | 47.5 |
De Waal E., et al. [56] | 2009 | 22 | 22 | 10 ml/kg | 10 | HES 6% | PICCO2 | SVI ≥ 12% | 83.3 | Zlicar M., et al. [35] | 2018 | 56 | 56 | 3mL/kg | > 5 | HES 6% | LiDCO | nSI ≥ 10% | 73.0 |
Biais M., et al. [57] | 2010 | 27 | 54 | 500 | 10 | HES 6% | Vigileo System | SVI ≥ 10% | 63.0 | Kim D.-H., et al. [36] | 2018 | 53 | 53 | 6ml/kg | 10 | HES 6% | CardioQ | SVI ≥ 15% | 75.0 |
Suheiro K., et al. [58] | 2010 | 30 | 30 | 500 | 30 | HES 6% | Vigileo/Flotrac | SVI ≥ 25% | 50.0 | Weil G., et al. [31] | 2019 | 49 | 115 | 250 | 5 | HES 6% | Mixed | SVOD ≥ 15% | 62.6 |
Cannesson M.,et al. [8] | 2011 | 413 | 413 | 500 | 10–20 | Colloids | Mixed | CO ≥ 15% | 51.0 | Joosten A., et al. [21] | 2019 | 57 | 57 | 5mL/kg | 10 | Other colloid | Mixed | COTD ≥ 10% | 46.0 |
Lee J.-H., et al. [59] | 2011 | 49 | 49 | 7 ml/kg | 7mL/kg/min | HES 6% | TEE | CI > 15% | 72.0 | Jun J.-H., et al. [34] | 2019 | 38 | 38 | 6mL/kg | 10 | HES 6% | CardioQ | SVI ≥ 10% | 63 |
Høiseth, L., et al. [60] | 2011 | 25 | 34 | 250 | 2–2.5 | HES 6% | Mixed | SV ≥ 15% | 64.7 | Messina A., et al. [26] | 2019 | 40 | 40 | 250 | 10 | Ringer’s Lactate | MostCare | SVI > 10% | 52.5 |
Biais M., et al. [61] | 2011 | 35 | 35 | 500 | 10 | HES 6% | Vigileo/Flotrac | SV ≥ 15% | 57.1 | Ali A., et al. [62] | 2019 | 88 | 88 | 500 | 10 | Saline 0.9% | Vigileo/Flotrac | SVI ≥ 15% | 44.0 |
Suheiro K., et al.[63] | 2011 | 73 | 73 | 500 | 30 | HES 6% | Vigileo/Flotrac | CI ≥ 15% | 64.0 | Vistisen S.T., et al. [64] | 2019 | 61 | 122 | 5mL/kg | 10 | Saline 0.9% | Vigileo/Flotrac | SV > 10% | 56.7 |
Høiseth, L., et al. [65] | 2012 | 20 | 22 | 250 | 2–2.5 | HES 6% | Mixed | SVOD ≥ 15% | 31.8 | Ali A., et al. [66] | 2019 | 48 | 48 | 500 | 10 | Saline 0.9% | Vigileo/Flotrac | SVI ≥ 15% | 44.0 |
Kim S.Y., et al. [67] | 2013 | 66 | 500 | 15–20 | HES 6% | Mixed | SVI ≥ 12% | 63.6 | Ali A., et al. [68] | 2019 | 33 | 66 | 500 | 10 | Saline 0.9% | Vigileo/Flotrac | SVI ≥ 15% | 45.0 | |
Seo H., et al. [69] | 2015 | 39 | 39 | 500 | 20 | HES 6% | Vigileo/Flotrac | MAP ≥ \ 15% | 44.0 | Kimura A., et al. [33] | 2021 | 30 | 30 | 250 | 10 | HES 6% | Vigileo/Flotrac | SV/MAP ≥ 10% | 57.0 |
Berger K., et al. [70] | 2015 | 52 | 52 | 250 | 30 | HES 6% | Vigileo/Flotrac | SVI ≥ 20 | 42.3 | Watanabe R., et al. [71] | 2021 | 30 | 30 | 250 | 10 | HES 6% | Vigileo/Flotrac | SVI ≥ 15% | 43.3 |
Tusman G., et al. [72] | 2016 | 52 | 52 | 500 | 10 | Saline 0.9% | PiCCO | CI ≥ 15% | 40.0 | Kimura A., et al. [29] | 2022 | 30 | 30 | 250 | 10 | HES 6% | Vigileo/Flotrac | SV > 10% | 67.0 |
Montenij L.J., et al. [73] | 2016 | 22 | 22 | 7mL/kg | 15 | Saline 0.9% | Vigileo/Flotrac | CO ≥ 15% | 40.9 | Flick M., et al. [74] | 2022 | 33 | 33 | 500 | NA | Saline 0.9% | PAC | CI > 15% | 39.0 |
Shen J., et al. [[24] | 2022 | 80 | 80 | 6mL/kg | 10 | HES 6% | TTE | SVI ≥ 15% | 55.0 |